Follow-up
death
EVENTS
The median follow-up time was 23 months (range, 19–33 months for patients who were alive; Treatment response duration and follow-up of patients enrolled in the phase I trial. Swimmer lane plot of time on study, noting the period from prior neoadjuvant chemotherapy to study start in the 4 patients who had prior treatment, the period of time on study drugs, the pathologic response assessment, timing of surgery, and follow-up period with events of progression or death.